上海市医疗机构国谈药品遴选与评价指标体系研究

A National Negotiated Drug Selection and Evaluation Index System for Medical Institutions in Shanghai

目的探索构建医疗机构国谈药品遴选与评价指标体系,为医疗机构药品准入提供评价工具。方法通过现状调研和文献回顾,构建指标体系框架,邀请上海市20家医疗机构药剂科主任进行两轮咨询,采用层次分析法计算各级指标权重。结果形成了包含4个一级指标、8个二级指标、17个三级指标的国谈药品遴选与评价指标体系。两轮咨询专家积极系数分别为80%、100%,专家权威系数为0.90;两轮专家咨询的三级指标重要性评分变异系数均值分别为0.138、0.107,可获得性评分变异系数均值分别为0.167、0.133。进院需求、临床价值、经济价值、医院管理4个一级指标权重分别为29.99%、38.20%、15.40%、16.41%。结论构建的上海市医疗机构国谈药品遴选与评价指标体系具有一定科学性,可为医疗机构药品准入管理提供工具支持。

Objective To explore the establishment of a selection and evaluation index system for national negotiated drug in medical institutions,and to provide evaluation tool for drug access in medical institutions.Methods Based on the current situation investigation and literature review,the index system framework was constructed,and 20 pharmacy directors from Shanghai medical institutions were invited to conduct two rounds of consultation,and the weights of indicators at all levels were calculated using analytic hierarchy process.Results A national negotiated drug selection and evaluation index system consisting of 4 first-level indexes,8 second-level indexes and 17 third-level indexes was formed.The positive coefficients of experts in the two rounds of consultation were 80%,100%,and the coefficient of expert authority was 0.90.For the two rounds of expert consultation,the mean coefficient of variation of the importance score were 0.138 and 0.107,and the mean coefficient of variation of the accessibility score were 0.167 and 0.133,respectively.The weights of the four first-level indicators of admission demand,clinical value,economic value and hospital management were 29.99%,38.20%,15.40%and 16.41%,respectively.Conclusion The established index system of national negotiated drug selection and evaluation in Shanghai medical institutions is scientific and can provide tools for drug access management in medical institutions.